Rowland R, Korolchuk S, Salamina M, Tatum N, Ault J, Hart S
Nat Commun. 2024; 15(1):6807.
PMID: 39122719
PMC: 11316097.
DOI: 10.1038/s41467-024-51135-w.
Gao C, Fan X, Liu Y, Han Y, Liu S, Li H
Int J Gen Med. 2023; 16:5817-5839.
PMID: 38106976
PMC: 10723185.
DOI: 10.2147/IJGM.S438479.
Harmalkar A, Lyskov S, Gray J
bioRxiv. 2023; .
PMID: 37546760
PMC: 10402144.
DOI: 10.1101/2023.07.28.551063.
Reinhardt R, Leonard T
Elife. 2023; 12.
PMID: 37470698
PMC: 10359097.
DOI: 10.7554/eLife.88210.
Reinhardt R, Hirzel K, Link G, Eisler S, Hagele T, Parson M
Proc Natl Acad Sci U S A. 2023; 120(7):e2212909120.
PMID: 36745811
PMC: 9962925.
DOI: 10.1073/pnas.2212909120.
A ROS-dependent mechanism promotes CDK2 phosphorylation to drive progression through S phase.
Kirova D, Judasova K, Vorhauser J, Zerjatke T, Leung J, Glauche I
Dev Cell. 2022; 57(14):1712-1727.e9.
PMID: 35809563
PMC: 9616724.
DOI: 10.1016/j.devcel.2022.06.008.
Activation of the essential kinase PDK1 by phosphoinositide-driven trans-autophosphorylation.
Levina A, Fleming K, Burke J, Leonard T
Nat Commun. 2022; 13(1):1874.
PMID: 35387990
PMC: 8986801.
DOI: 10.1038/s41467-022-29368-4.
SCP4-STK35/PDIK1L complex is a dual phospho-catalytic signaling dependency in acute myeloid leukemia.
Polyanskaya S, Moreno R, Lu B, Feng R, Yao Y, Irani S
Cell Rep. 2022; 38(2):110233.
PMID: 35021089
PMC: 8796272.
DOI: 10.1016/j.celrep.2021.110233.
Structure of autoinhibited Akt1 reveals mechanism of PIP-mediated activation.
Truebestein L, Hornegger H, Anrather D, Hartl M, Fleming K, Stariha J
Proc Natl Acad Sci U S A. 2021; 118(33).
PMID: 34385319
PMC: 8379990.
DOI: 10.1073/pnas.2101496118.
Allostery governs Cdk2 activation and differential recognition of CDK inhibitors.
Majumdar A, Burban D, Muretta J, Thompson A, Engel T, Rasmussen D
Nat Chem Biol. 2021; 17(4):456-464.
PMID: 33526892
PMC: 7990704.
DOI: 10.1038/s41589-020-00725-y.
CDKN3 promotes cell proliferation, invasion and migration by activating the AKT signaling pathway in esophageal squamous cell carcinoma.
Yu H, Yao J, Du M, Ye J, He X, Yin L
Oncol Lett. 2020; 19(1):542-548.
PMID: 31897169
PMC: 6924098.
DOI: 10.3892/ol.2019.11077.
Structural insights into the functional diversity of the CDK-cyclin family.
Wood D, Endicott J
Open Biol. 2018; 8(9).
PMID: 30185601
PMC: 6170502.
DOI: 10.1098/rsob.180112.
Expression and alternative splicing of the cyclin-dependent kinase inhibitor-3 gene in human cancer.
Cress W, Yu P, Wu J
Int J Biochem Cell Biol. 2017; 91(Pt B):98-101.
PMID: 28504190
PMC: 5641230.
DOI: 10.1016/j.biocel.2017.05.013.
Differential regulation of PKD isoforms in oxidative stress conditions through phosphorylation of a conserved Tyr in the P+1 loop.
Cobbaut M, Derua R, Doppler H, Lou H, Vandoninck S, Storz P
Sci Rep. 2017; 7(1):887.
PMID: 28428613
PMC: 5430542.
DOI: 10.1038/s41598-017-00800-w.
Cyclin-Dependent Kinase Inhibitor 3 Promotes Cancer Cell Proliferation and Tumorigenesis in Nasopharyngeal Carcinoma by Targeting p27.
Wang H, Chen H, Zhou H, Yu W, Lu Z
Oncol Res. 2017; 25(9):1431-1440.
PMID: 28109073
PMC: 7840971.
DOI: 10.3727/096504017X14835311718295.
Knockdown of Cyclin-Dependent Kinase Inhibitor 3 Inhibits Proliferation and Invasion in Human Gastric Cancer Cells.
Li Y, Ji S, Fu L, Jiang T, Wu D, Meng F
Oncol Res. 2016; 25(5):721-731.
PMID: 27983933
PMC: 7841180.
DOI: 10.3727/096504016X14772375848616.
Protein phosphorylation and its role in archaeal signal transduction.
Esser D, Hoffmann L, Pham T, Brasen C, Qiu W, Wright P
FEMS Microbiol Rev. 2016; 40(5):625-47.
PMID: 27476079
PMC: 5007285.
DOI: 10.1093/femsre/fuw020.
A conserved motif in JNK/p38-specific MAPK phosphatases as a determinant for JNK1 recognition and inactivation.
Liu X, Zhang C, Lu C, Lin S, Wu J, Wang Z
Nat Commun. 2016; 7:10879.
PMID: 26988444
PMC: 4802042.
DOI: 10.1038/ncomms10879.
Structural mechanisms of plant glucan phosphatases in starch metabolism.
Meekins D, Vander Kooi C, Gentry M
FEBS J. 2016; 283(13):2427-47.
PMID: 26934589
PMC: 4935604.
DOI: 10.1111/febs.13703.
Overexpression of major CDKN3 transcripts is associated with poor survival in lung adenocarcinoma.
Fan C, Chen L, Huang Q, Shen T, Welsh E, Teer J
Br J Cancer. 2015; 113(12):1735-43.
PMID: 26554648
PMC: 4701993.
DOI: 10.1038/bjc.2015.378.